Share Email Print
cover

Proceedings Paper

Effect of GFP expression on the sensitivity of glioma cell lines to photodynamic therapy
Author(s): S. Khatami; A. Rendon; M. Yoshimitsu; J. Medin; L. Lilge
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Enhanced green fluorescent protein (EGFP)-expressing cells are customarily used in a variety of in vitro and in vivo studies and assays to ease visualization and localization. Nonetheless, the effects of EGFP expression on cellular responsivity to Photodynamic therapy (PDT), a combination therapy combining a photoactive drug and light, have yet to be characterized. To address this effect, rat astrocytoma cells (CNS-1), a lentivirus-transduced EGFP variant (CNS-1 GFP), human glioblastoma (U-87), and the transfected EGFP variant (U-87 GFP) are analyzed in terms of cell survival following PDT mediated by two different photoactive drugs. Cell survival is quantified via colony forming assays and Alamar blue assays, as a function of light dose, using the photosensitizers Photofrin (1ug ml-1 for 24h) and ALA (200ug ml-1 for 5h). Furthermore, effect of GFP expression on the responsivity to Cisplatin, a DNA-binding chemotherapeutic agent is determined for these cell lines. Our results show that EGFP expression does not affect the responsivity of Photofrin-PDT in comparison to parental cell lines (non GFP expressing cells), but does alter that of ALA-PDT. No change in responsivity is observed for Cisplatin treatment for either cell line. These results can be explained by oxidative stress induced by EGFP expression. This work will establish under which circumstances it is appropriate to use EGFP-expressing cell lines in the context of PDT preclinical research in vivo and in vitro.

Paper Details

Date Published: 13 October 2005
PDF: 7 pages
Proc. SPIE 5969, Photonic Applications in Biosensing and Imaging, 596923 (13 October 2005); doi: 10.1117/12.628706
Show Author Affiliations
S. Khatami, Ontario Cancer Institute (Canada)
A. Rendon, Univ. of Toronto (Canada)
M. Yoshimitsu, Canadian Blood Services (Canada)
J. Medin, Univ. of Toronto (Canada)
Canadian Blood Services (Canada)
L. Lilge, Ontario Cancer Institute (Canada)
Univ. of Toronto (Canada)


Published in SPIE Proceedings Vol. 5969:
Photonic Applications in Biosensing and Imaging
Brian C. Wilson; Richard I. Hornsey; Warren C. W. Chan; Ulrich J. Krull; Robert A. Weersink; Kui Yu, Editor(s)

© SPIE. Terms of Use
Back to Top